Vinorelbine In Combination with the mTOR Inhibitor Everolimus vs Vinorelbine monotherapy in Advanced breast cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-001024-38

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary study goal is the evaluation of Progression-free survival (PFS)


Critère d'inclusion

  • local advanced metastatic breat cancer, second line therapy for patients who did not respond to treatment with anthracyclines or taxanes or are not suitable for such treatment

Liens